|
Bioniche Life Sciences Inc. is a leading, fully-integrated biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide.
Latest News
May 9, 2008
Bioniche Reports Fiscal 2008 Third Quarter
more...
April 21, 2008
Bioniche Appoints U.S. President of Food Safety
more...
April 18, 2008
Bioniche Reports the Passing of its Board Chair
more...
More News
|
 |

Bioniche Key Facts
Founded: 1979
President & CEO: Graeme McRae
TSX stock symbol: BNC
Fiscal year-end: June 30
2006 revenues: C$26.7 million
Headquarters: Belleville, Ontario
Employees worldwide: 188
Business divisions: Human Health, Animal Health, Food Safety
Focus areas: Human Health:
cancer, immunomodulation
Animal Health: reproduction,
vaccines, replacement of antibiotics
Food Safety: E. coli O157 vaccine, other veterinary biopharmaceutical products to address diseases in livestock which may have an effect on human health
Top products:
Animal Health: Folltropin®, MAP 5®
|